Sabitlenmiş Tweet

Exciting news from KAIMRC!
Our Drug Discovery Program has just published a paper entitled “First-in-class inhibitors of Nsp15 endoribonuclease of SARS-CoV-2: modeling, synthesis, and enzymatic assay of thiazolidinedione and rhodanine analogs” in JBC, one of the world’s leading scientific journals.
All work was done exclusively at KAIMRC — from concept to product.
Watch the video for highlights and read the full paper here: jbc.org/article/S0021-…
#DrugDiscovery #COVID19Research #SARSCoV2 #AntiviralTherapeutics #Nsp15Inhibitors #KAIMRCResearch #ScienceInnovation #JBCPublication
English





















